PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $252,637 | +158.9% | 177,913 | +109.7% | 0.00% | – |
Q2 2023 | $97,581 | -60.5% | 84,853 | -63.6% | 0.00% | – |
Q1 2023 | $247,021 | +10.8% | 233,039 | +58.9% | 0.00% | – |
Q4 2022 | $222,908 | -43.3% | 146,650 | -20.9% | 0.00% | – |
Q3 2022 | $393,000 | +3.1% | 185,348 | -34.9% | 0.00% | – |
Q2 2022 | $381,000 | -54.6% | 284,851 | -28.4% | 0.00% | – |
Q1 2022 | $839,000 | -89.7% | 397,721 | -81.8% | 0.00% | – |
Q4 2021 | $8,114,000 | +52.5% | 2,187,258 | +105.2% | 0.00% | – |
Q3 2021 | $5,320,000 | -16.1% | 1,066,148 | +9.6% | 0.00% | – |
Q2 2021 | $6,342,000 | +3.9% | 972,766 | +9.8% | 0.00% | -100.0% |
Q1 2021 | $6,103,000 | -76.9% | 885,764 | -65.9% | 0.00% | -50.0% |
Q4 2020 | $26,472,000 | +778.0% | 2,595,324 | +201.3% | 0.00% | – |
Q3 2020 | $3,015,000 | -41.8% | 861,261 | -17.0% | 0.00% | -100.0% |
Q2 2020 | $5,178,000 | +102.1% | 1,037,702 | +37.7% | 0.00% | – |
Q1 2020 | $2,562,000 | – | 753,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |